We refer to our announcements dated 12 and 14 January 2021 respectively.

The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Lifescience Sdn Bhd (“PLS”), a wholly-owned subsidiary of the Company has on 12 March 2021 entered into an Agreement with Sinovac Life Sciences Co. Ltd., a subsidiary of Sinovac Biotech Ltd. for the purchase of ready-to-fill bulk product of Covid-19 vaccine for manufacturing of Covid-19 vaccine by PLS in Malaysia.

Please refer to the attachment for details of the announcement.

This announcement is dated 15 March 2021.